DV
Dividend Vision

OMCL — Omnicell, Inc.

Omnicell, Inc. (OMCL)

Total return is 292.2% over the past 25 years, 617.4 points behind SPY at 909.6%. Its deepest 1-year drawdown was 37.1%.

OMCL is a single-stock equity holding in Omnicell, Inc., a healthcare technology company, rather than a diversified ETF fund. The stock does not currently pay a dividend, resulting in no distribution yield or frequency. This holding appeals primarily to growth-oriented investors seeking exposure to the healthcare automation and medication management sector rather than income-focused investors.

OMCL key facts

Asset type
Stock
Asset class
Equity
Inception date
08/07/2001
Distribution frequency
None
Last close
$37.30
Market cap
$1,696,363,264
Average volume
393600.0
Beta
0.973
Payout ratio
0.0
P/E ratio
44.4048
Forward P/E
29.4985
EPS
$0.84